1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ZEVRA THERAPEUTICS INC
Zevra Therapeutics Inc XNAS: ZVRA

Zevra Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Await Turnaround
about

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people...

Read More
8.88 -0.35 (-3.79%)
32.52% Fall from 52W High
1.8M
XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
41.8 / 100
Momentum Score
Technically Neutral
45.2 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM
Analyst Price Target
23
1Yr Price target upside is 161%
8 analysts

4

S

18

W

6

O

0

T

SWOT Analysis

Zevra Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..